NASDAQ:ARYD

ARYA Sciences Acquisition Corp IV Competitors

$10.81
-0.08 (-0.73 %)
(As of 04/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.80
Now: $10.81
$11.01
50-Day Range
$10.44
MA: $10.78
$11.55
52-Week Range
$10.34
Now: $10.81
$12.38
Volume26,835 shs
Average Volume78,326 shs
Market Capitalization$180.64 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Vs. IKNA, ADAG, CTOS, LVTX, FWAA, and SVFC

Should you be buying ARYD stock or one of its competitors? Companies in the industry of "--" are considered alternatives and competitors to ARYA Sciences Acquisition Corp IV, including Ikena Oncology (IKNA), Adagene (ADAG), Custom Truck One Source (CTOS), Lava Therapeutics B.V. (LVTX), Fifth Wall Acquisition Corp. I (FWAA), and SVF Investment Corp. 3 (SVFC).

Ikena Oncology (NASDAQ:IKNA) and ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) are both small-cap -- companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations and profitability.

Profitability

This table compares Ikena Oncology and ARYA Sciences Acquisition Corp IV's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ikena OncologyN/AN/AN/A
ARYA Sciences Acquisition Corp IVN/AN/AN/A

Earnings and Valuation

This table compares Ikena Oncology and ARYA Sciences Acquisition Corp IV's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ikena OncologyN/AN/AN/AN/AN/A
ARYA Sciences Acquisition Corp IVN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Ikena Oncology and ARYA Sciences Acquisition Corp IV, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ikena Oncology0000N/A
ARYA Sciences Acquisition Corp IV0000N/A

ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) and Adagene (NASDAQ:ADAG) are both small-cap -- companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends and institutional ownership.

Profitability

This table compares ARYA Sciences Acquisition Corp IV and Adagene's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ARYA Sciences Acquisition Corp IVN/AN/AN/A
AdageneN/AN/AN/A

Earnings and Valuation

This table compares ARYA Sciences Acquisition Corp IV and Adagene's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ARYA Sciences Acquisition Corp IVN/AN/AN/AN/AN/A
AdageneN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for ARYA Sciences Acquisition Corp IV and Adagene, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ARYA Sciences Acquisition Corp IV0000N/A
Adagene00303.00

Adagene has a consensus target price of $32.00, indicating a potential upside of 137.74%. Given Adagene's higher possible upside, analysts clearly believe Adagene is more favorable than ARYA Sciences Acquisition Corp IV.

Summary

Adagene beats ARYA Sciences Acquisition Corp IV on 2 of the 2 factors compared between the two stocks.

Custom Truck One Source (NYSE:CTOS) and ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) are both small-cap -- companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, risk, valuation, profitability and institutional ownership.

Analyst Ratings

This is a summary of current ratings and recommmendations for Custom Truck One Source and ARYA Sciences Acquisition Corp IV, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Custom Truck One Source00103.00
ARYA Sciences Acquisition Corp IV0000N/A

Given Custom Truck One Source's higher possible upside, research analysts plainly believe Custom Truck One Source is more favorable than ARYA Sciences Acquisition Corp IV.

Profitability

This table compares Custom Truck One Source and ARYA Sciences Acquisition Corp IV's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Custom Truck One SourceN/AN/AN/A
ARYA Sciences Acquisition Corp IVN/AN/AN/A

Earnings & Valuation

This table compares Custom Truck One Source and ARYA Sciences Acquisition Corp IV's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Custom Truck One SourceN/AN/AN/AN/AN/A
ARYA Sciences Acquisition Corp IVN/AN/AN/AN/AN/A

Summary

Custom Truck One Source beats ARYA Sciences Acquisition Corp IV on 2 of the 2 factors compared between the two stocks.

ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) and Lava Therapeutics B.V. (NASDAQ:LVTX) are both small-cap -- companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations.

Earnings and Valuation

This table compares ARYA Sciences Acquisition Corp IV and Lava Therapeutics B.V.'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ARYA Sciences Acquisition Corp IVN/AN/AN/AN/AN/A
Lava Therapeutics B.V.N/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and price targets for ARYA Sciences Acquisition Corp IV and Lava Therapeutics B.V., as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ARYA Sciences Acquisition Corp IV0000N/A
Lava Therapeutics B.V.0000N/A

Profitability

This table compares ARYA Sciences Acquisition Corp IV and Lava Therapeutics B.V.'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ARYA Sciences Acquisition Corp IVN/AN/AN/A
Lava Therapeutics B.V.N/AN/AN/A

Fifth Wall Acquisition Corp. I (NASDAQ:FWAA) and ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) are both small-cap -- companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, dividends and profitability.

Profitability

This table compares Fifth Wall Acquisition Corp. I and ARYA Sciences Acquisition Corp IV's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Fifth Wall Acquisition Corp. IN/AN/AN/A
ARYA Sciences Acquisition Corp IVN/AN/AN/A

Earnings & Valuation

This table compares Fifth Wall Acquisition Corp. I and ARYA Sciences Acquisition Corp IV's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fifth Wall Acquisition Corp. IN/AN/AN/AN/AN/A
ARYA Sciences Acquisition Corp IVN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for Fifth Wall Acquisition Corp. I and ARYA Sciences Acquisition Corp IV, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Fifth Wall Acquisition Corp. I0000N/A
ARYA Sciences Acquisition Corp IV0000N/A

ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) and SVF Investment Corp. 3 (NASDAQ:SVFC) are both small-cap -- companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for ARYA Sciences Acquisition Corp IV and SVF Investment Corp. 3, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ARYA Sciences Acquisition Corp IV0000N/A
SVF Investment Corp. 30000N/A

Valuation and Earnings

This table compares ARYA Sciences Acquisition Corp IV and SVF Investment Corp. 3's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ARYA Sciences Acquisition Corp IVN/AN/AN/AN/AN/A
SVF Investment Corp. 3N/AN/AN/AN/AN/A

Profitability

This table compares ARYA Sciences Acquisition Corp IV and SVF Investment Corp. 3's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ARYA Sciences Acquisition Corp IVN/AN/AN/A
SVF Investment Corp. 3N/AN/AN/A


ARYA Sciences Acquisition Corp IV Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
IKNA
Ikena Oncology
0.0$17.89-3.9%$618.78 millionN/A0.00News Coverage
Gap Up
Adagene logo
ADAG
Adagene
1.7$13.46-0.2%$582.59 millionN/A0.00News Coverage
CTOS
Custom Truck One Source
1.0$9.34-5.2%$457.98 millionN/A0.00Analyst Report
News Coverage
LVTX
Lava Therapeutics B.V.
0.0$16.00-6.2%$405.63 millionN/A0.00
FWAA
Fifth Wall Acquisition Corp. I
0.0$10.10-1.1%$388.43 millionN/A0.00
SVFC
SVF Investment Corp. 3
0.3$10.15-0.0%$364.99 millionN/A0.00Quiet Period Expiration
PLBY Group logo
PLBY
PLBY Group
1.1$38.11-18.7%$287.46 millionN/A0.00Analyst Report
High Trading Volume
SVFB
SVF Investment Corp. 2
0.3$10.22-0.3%$262.65 millionN/A0.00Quiet Period Expiration
VHAQ
Viveon Health Acquisition
0.0$9.98-0.0%$251.06 millionN/A0.00
WNW
Wunong Net Technology
0.0$9.53-3.9%$238.25 millionN/A0.00
HCAQ
HealthCor Catalio Acquisition
0.0$10.06-1.4%$208.24 millionN/A0.00
RACB
Research Alliance Corp. II
0.0$10.90-1.4%$182.14 millionN/A0.00
ABGI
ABG Acquisition Corp. I
0.0$9.96-0.5%$167.70 millionN/A0.00
VVOS
Vivos Therapeutics
1.4$8.65-5.8%$157.53 millionN/A0.00Increase in Short Interest
Biophytis logo
BPTS
Biophytis
0.0$13.92-15.3%$157.48 millionN/A0.00News Coverage
CCV
Churchill Capital Corp V
0.0$10.03-0.4%$146.40 millionN/A0.00
MRAC
Marquee Raine Acquisition
0.0$9.97-0.2%$109.68 millionN/A0.00
EEIQ
Elite Education Group International
0.0$6.07-7.6%$53.42 millionN/A0.00Gap Up
Presidio Property Trust logo
SQFT
Presidio Property Trust
0.3$3.61-3.6%$35.72 millionN/A0.00
LBPS
4D pharma
1.0$12.59-1.1%$33.06 millionN/A0.00
IGNY
Ignyte Acquisition
0.0$9.81-0.0%$19.03 millionN/A0.00
AFAQU
AF Acquisition Corp. Units
0.0$9.95-0.5%$0.00N/A0.00News Coverage
ANZUU
Anzu Special Acquisition Corp I Units
0.0$10.09-0.3%$0.00N/A0.00Quiet Period Expiration
ATSPU
Archimedes Tech SPAC Partners Co. Unit
0.0$9.95-0.0%$0.00N/A0.00News Coverage
ARRWU
Arrowroot Acquisition Corp. Unit
0.0$10.05-0.3%$0.00N/A0.00Quiet Period Expiration
AUUD
Auddia
0.0$2.82-5.0%$0.00N/A0.00
BSA
BrightSphere Investment Group
0.0$25.12-0.2%$0.00N/A0.00Decrease in Short Interest
CMLTU
CM Life Sciences III Inc. Unit
0.0$11.18-1.6%$0.00N/A0.00
CRZNU
Corazon Capital V838 Monoceros
0.0$10.02-0.1%$0.00N/A0.00
DCRCU
Decarbonization Plus Acquisition Corp III
0.0$10.05-0.4%$0.00N/A0.00
DLY
DoubleLine Yield Opportunities Fund
0.0$19.65-0.0%$0.00N/A0.00News Coverage
EBACU
European Biotech Acquisition Corp. Units
0.0$10.10-0.5%$0.00N/A0.00
EVOJ
Evo Acquisition
0.3$9.75-0.5%$0.00N/A0.00
FRSGU
First Reserve Sustainable Growth Corp. Unit
0.0$10.10-0.0%$0.00N/A0.00Quiet Period Expiration
FMIVU
Forum Merger IV Co. Unit
0.0$10.10-0.4%$0.00N/A0.00
FRONU
Frontier Acquisition Corp. Units
0.0$10.08-0.8%$0.00N/A0.00
HERAU
FTAC Hera Acquisition
0.0$10.03-0.0%$0.00N/A0.00Quiet Period Expiration
GLHAU
Glass Houses Acquisition Corp. Unit
0.0$10.10-0.6%$0.00N/A0.00
GLSPU
Global SPAC Partners Co. Unit
0.0$9.98-0.0%$0.00N/A0.00
GMLPP
Golar LNG Partners LP 8.75% CUM PFD A
0.8$25.88-0.3%$0.00N/A0.00Increase in Short Interest
News Coverage
GAMCU
Golden Arrow Merger Corp. Unit
0.0$10.00-0.0%$0.00N/A0.00
GBRGU
Goldenbridge Acquisition Limited Unit
0.0$10.06-0.3%$0.00N/A0.00Quiet Period Expiration
GSEVU
Gores Holdings VII
0.0$10.20-0.4%$0.00N/A0.00
HGLB
Highland Global Allocation Fund
0.3$8.31-0.8%$0.00N/A0.00Dividend Announcement
IPVIU
InterPrivate IV InfraTech Partners Inc. Units
0.0$9.97-1.3%$0.00N/A0.00Quiet Period Expiration
ISLEU
Isleworth Healthcare Acquisition
0.0$9.90-0.3%$0.00N/A0.00
KSICU
Kadem Sustainable Impact Co. Unit
0.0$9.95-0.0%$0.00N/A0.00
LCAAU
L Catterton Asia Acquisition Corp Units
0.0$10.05-0.5%$0.00N/A0.00News Coverage
LEGAU
Lead Edge Growth Opportunities, Ltd Units
0.0$9.99-0.1%$0.00N/A0.00
LVRAU
Levere Holdings Corp. Unit
0.0$10.05-0.1%$0.00N/A0.00
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.